Standout Papers

Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failu... 2020 2026 2022 2024219
  1. Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure (2020)
    Jordan Gauthier, Alexandre V. Hirayama et al. Blood

Immediate Impact

5 from Science/Nature 67 standout
Sub-graph 1 of 22

Citing Papers

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Novel strategies to manage CAR-T cell toxicity
2025 Standout
1 intermediate paper

Works of Aesha Vakil being referenced

Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure
2020 Standout

Author Peers

Author Last Decade Papers Cites
Aesha Vakil 363 126 121 151 16 459
Rachel N. Steinmetz 382 184 110 156 17 562
Barbara S. Pender 362 100 115 139 19 432
Steven Park 274 124 116 218 28 497
Ian R. Hardy 410 179 56 58 10 538
Meg Elias 520 149 25 87 15 551
Priscilla Do 204 88 203 143 18 441
Zahra Asgari 308 198 41 96 16 517
Shui‐on Leung 168 164 52 124 28 468
Nicole Adrian 319 84 65 189 10 421
Misa Imai 247 238 148 30 23 523

All Works

Loading papers...

Rankless by CCL
2026